Journal of Clinical Endocrinology & Metabolism, Vol 79, 1212-1214, Copyright © 1994 by Endocrine Society

ARTICLES

Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man

E Spath-Schwalbe, J Born, H Schrezenmeier, SR Bornstein, P Stromeyer, S Drechsler, HL Fehm and F Porzsolt
Department of Internal Medicine, University of Ulm, Germany.

A recent study in humans, animal studies, and in vitro data have suggested that interleukin-6 (IL-6) stimulates the secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis. In a phase II study, one female and six male patients with metastatic renal cell carcinoma received IL-6 to evaluate a possible antitumor effect of IL- 6. This offered the possibility of investigating the influence of IL-6 on the HPA axis in man. The subjects were studied 1 day before, on day 1, and on day 21 of IL-6 therapy (150 micrograms administered sc every day at 0900 h). Blood samples were taken at 0900, 1100, 1300, 1600, and 2000 h the day before, on day 1 of IL-6 therapy, 24 h after the first IL-6 injection, and on day 21 of IL-6 treatment. Plasma ACTH and cortisol levels promptly followed the rise of IL-6, which peaked 4 h after administration. They were significantly (P < 0.05) higher at 1100 and 1300 h on day 1 of IL-6 therapy compared with the corresponding plasma levels the day before IL-6 treatment. Cortisol concentrations remained significantly increased at 1600 and 2000 h after IL-6 administration. Twenty-four hours after the first IL-6 administration, IL-6, ACTH, and cortisol levels had reached preinjection values. Although plasma cortisol levels were similar on days 1 and 21, ACTH levels were lower on day 21 (than on day 1), but significantly elevated at 1100 h compared with levels on the day before the first IL-6 injection. Results confirming the very recent data of another study demonstrate a stimulating effect of IL-6 on the HPA axis in man. They support the notion that IL-6 is one of the cytokines involved in the interaction between the immune system and the HPA axis.

This article has been cited by other articles:

				S. Dimitrov, T. Lange, C. Benedict, M. A. Nowell, S. A. Jones, J. Scheller, S. Rose-John, and J. Born Sleep enhances IL-6 trans-signaling in humans FASEB J, October 1, 2006; 20(12): 2174 - 2176. [Abstract] [Full Text] [PDF]

				P Harle, R H Straub, R Wiest, A Mayer, J Scholmerich, F Atzeni, M Carrabba, M Cutolo, and P Sarzi-Puttini Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems Ann Rheum Dis, January 1, 2006; 65(1): 51 - 56. [Abstract] [Full Text] [PDF]

				R H Straub, P Sarzi-Puttini, F Atzeni, F Buttgereit, M Carrabba, and M Cutolo Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol Ann Rheum Dis, September 1, 2005; 64(9): 1353 - 1356. [Abstract] [Full Text] [PDF]

				M. D'Elia, J. Patenaude, C. Hamelin, D. R. Garrel, and J. Bernier Corticosterone binding globulin regulation and thymus changes after thermal injury in mice Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E852 - E860. [Abstract] [Full Text] [PDF]

				S. J. Woods Intimate Partner Violence and Post-Traumatic Stress Disorder Symptoms in Women: What We Know and Need to Know J Interpers Violence, April 1, 2005; 20(4): 394 - 402. [Abstract] [PDF]

				C. Benedict, M. Hallschmid, J. Scheibner, D. Niemeyer, B. Schultes, V. Merl, H. L. Fehm, J. Born, and W. Kern Gut Protein Uptake and Mechanisms of Meal-Induced Cortisol Release J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1692 - 1696. [Abstract] [Full Text] [PDF]

				M. N. Silverman, A. H. Miller, C. A. Biron, and B. D. Pearce Characterization of an Interleukin-6- and Adrenocorticotropin-Dependent, Immune-to-Adrenal Pathway during Viral Infection Endocrinology, August 1, 2004; 145(8): 3580 - 3589. [Abstract] [Full Text] [PDF]

				V. Morales, P. Santana, R. Diaz, C. Tabraue, G. Gallardo, F. L. Blanco, I. Hernandez, L. F. Fanjul, and C. M. Ruiz de Galarreta Intratesticular Delivery of Tumor Necrosis Factor-{alpha} and Ceramide Directly Abrogates Steroidogenic Acute Regulatory Protein Expression and Leydig Cell Steroidogenesis in Adult Rats Endocrinology, November 1, 2003; 144(11): 4763 - 4772. [Abstract] [Full Text] [PDF]

				A. Beishuizen and L. G. Thijs Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis Innate Immunity, February 1, 2003; 9(1): 3 - 24. [Abstract] [PDF]

				L. Redwine, R. L. Hauger, J. C. Gillin, and M. Irwin Effects of Sleep and Sleep Deprivation on Interleukin-6, Growth Hormone, Cortisol, and Melatonin Levels in Humans J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3597 - 3603. [Abstract] [Full Text]

				R. H. Straub, T. Gluck, M. Cutolo, J. Georgi, K. Helmke, J. Scholmerich, P. Vaith, and B. Lang The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica Rheumatology, June 1, 2000; 39(6): 624 - 631. [Abstract] [Full Text] [PDF]

				G. W. Wolkersdörfer, T. Lohmann, C. Marx, S. Schröder, R. Pfeiffer, H.-D. Stahl, W. A. Scherbaum, G. P. Chrousos, and S. R. Bornstein Lymphocytes Stimulate Dehydroepiandrosterone Production through Direct Cellular Contact with Adrenal Zona Reticularis Cells: A Novel Mechanism of Immune-Endocrine Interaction J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4220 - 4227. [Abstract] [Full Text]

				T. Tajima, X.-M. Ma, S. R. Bornstein, and G. Aguilera Prenatal Dexamethasone Treatment Does Not Prevent Alterations of the Hypothalamic Pituitary Adrenal Axis in Steroid 21-Hydroxylase Deficient Mice Endocrinology, July 1, 1999; 140(7): 3354 - 3362. [Abstract] [Full Text]

				S. R. Bornstein and G. P. Chrousos Adrenocorticotropin (ACTH)- and Non-ACTH-Mediated Regulation of the Adrenal Cortex: Neural and Immune Inputs J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1729 - 1736. [Full Text]

				E. Späth-Schwalbe, K. Hansen, F. Schmidt, H. Schrezenmeier, L. Marshall, K. Burger, H. L. Fehm, and J. Born Acute Effects of Recombinant Human Interleukin-6 on Endocrine and Central Nervous Sleep Functions in Healthy Men J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1573 - 1579. [Abstract] [Full Text]

				M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis Endocr. Rev., April 1, 1998; 19(2): 101 - 143. [Abstract] [Full Text]

				J. Raber, R. D. O'Shea, F. E. Bloom, and I. L. Campbell Modulation of Hypothalamic-Pituitary-Adrenal Function by Transgenic Expression of Interleukin-6 in the CNS of Mice J. Neurosci., December 15, 1997; 17(24): 9473 - 9480. [Abstract] [Full Text] [PDF]

				T. M. E. Davis, L. T. A. Thu, T. Q. Binh, K. Robertson, J. R. Dyer, P. T. Danh, D. Meyer, M. H. Beaman, and T. K. Anh The Hypothalamic-Pituitary-Adrenocortical Axis in Severe Falciparum Malaria: Effects of Cytokines J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3029 - 3033. [Abstract] [Full Text] [PDF]

				G. Path, S. R. Bornstein, M. Ehrhart-Bornstein, and W. A. Scherbaum Interleukin-6 and the Interleukin-6 Receptor in the Human Adrenal Gland: Expression and Effects on Steroidogenesis J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2343 - 2349. [Abstract] [Full Text] [PDF]

				L. J. Crofford, K. T. Kalogeras, G. Mastorakos, M.-A. Magiakou, J. Wells, K. S. Kanik, P. W. Gold, G. P. Chrousos, and R. L. Wilder Circadian Relationships between Interleukin (IL)-6 and Hypothalamic-Pituitary-Adrenal Axis Hormones: Failure of IL-6 to Cause Sustained Hypercortisolism in Patients with Early Untreated Rheumatoid Arthritis J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1279 - 1283. [Abstract] [Full Text] [PDF]